Allogene Therapeutics Inc
ALLO
$1.40-4.11%
End of day · as of Oct 13, 2026, 2:00 AM ET
Mkt cap
$258.10M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (TTM)
$-0.66
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
0.31
Div yield
N/A
Sector
Healthcare
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Latest reported ALLO revenue for 2025-12-31 was $0. Net income was -$190.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ALLO currently screens at market cap $258.1M.
Use this ALLO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ALLO income, balance, and cash tables.
Allogene Therapeutics Inc (ALLO) is a biotechnology company in the Healthcare sector.
Latest cached Allogene Therapeutics Inc (ALLO) net income for Dec 31, 2025 was -$190.9M. Statements: https://lician.com/financials/allo
Allogene Therapeutics Inc (ALLO) market capitalization is $258.1M on the latest cached snapshot.
Allogene Therapeutics Inc (ALLO) cached previous close $1.46; day range $1.40 – $1.45; volume 4,313,874. Session quote: https://lician.com/quote/allo
Allogene Therapeutics Inc (ALLO) latest cached earnings event is "ALLO earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ALLO filing is 8-K · Sep 2, 2026. Filings: https://lician.com/sec/allo